Introduction {#section5-1470320317741066}
============

Hypertension is thought to be a multifactorial disorder and is the major risk factor for cardiovascular disease.^[@bibr1-1470320317741066]^ According to the large epidemiological investigation, patients with essential hypertension (EH) accounted for 90% of patients with hypertension.^[@bibr2-1470320317741066]^ Although the etiology of EH has not been determined, genetic factors have a certain impact on it.^[@bibr3-1470320317741066],[@bibr4-1470320317741066]^

In recent years, several studies have indicated that inflammation plays an important role in the development of EH.^[@bibr5-1470320317741066],[@bibr6-1470320317741066]^ One study in 2015 showed that the levels of pro-inflammatory cytokines increased in EH patients, which suggested that an immune function disorder was associated with EH.^[@bibr7-1470320317741066]^ Tumor necrosis factor-a (TNF-a) stimulates cytokine production, which enhances the expression of adhesion molecules and increases neutrophil activation. Navarro-González et al. in 2008 found that the serum level of TNF-a was higher in hypertensive patients than in healthy controls.^[@bibr8-1470320317741066]^ A similar phenomenon was found in other studies.^[@bibr9-1470320317741066][@bibr10-1470320317741066]-[@bibr11-1470320317741066]^ TNF-a protein levels were predominantly under genetic control.^[@bibr12-1470320317741066]^ The TNF gene is located on chromosome 6, within the class III region of the human leukocyte antigen (HLA).^[@bibr13-1470320317741066]^ Of these polymorphisms, G-to-A substitutions at position -308 (rs1800629) have been widely studied.^[@bibr14-1470320317741066]^

Several studies have examined the relationship between TNF-a -308G/A polymorphism and EH, but the conclusions are often inconsistent. It may be difficult to achieve comprehensive and reliable results in an individual study due to sample size. In 2012, Li et al. performed a meta-analysis in order to clarify the effect of TNF-a -308G/A polymorphism on the risk of EH, which contained seven studies.^[@bibr14-1470320317741066]^ Since 2012, an expanding body of literature assessing the association between the TNF-a -308G/A polymorphism and hypertension has been published. It is widely accepted that the same polymorphism plays a different role in different ethnic populations. To derive a more precise estimation, we performed an updated meta-analysis of published studies to pool results between studies.

Materials and methods {#section6-1470320317741066}
=====================

Literature search strategy {#section7-1470320317741066}
--------------------------

The electronic databases of PubMed, the Chinese Biomedical Database (CBM), and the Chinese National Knowledge Infrastructure (CNKI) were searched up to April 2016 for all genetic association human studies evaluating TNF-a -308G/A polymorphism and EH. The following index terms were used: "hypertension" or "blood pressure," "tumor necrosis factor-alpha," "polymorphism or variant." Chinese and English articles were included. In addition, we read the titles of references of the selected articles.

Inclusion criteria and data extraction {#section8-1470320317741066}
--------------------------------------

We read all the titles and abstracts of the relevant articles. The following criteria were used to include published studies: (a) the publication was a case-control design; (b) the papers had available genotype frequency or had sufficient data to estimate an odds ratio (OR); and (c) the genotype distribution in the control group was in line with the Hardy Weinberg equilibrium (HWE).

According to the above criteria, the following information was extracted by two of the researchers country of origin from all eligible studies: the first author, the date of publication, ethnicity, number of genotypes, and genotyping information and frequencies of alleles. China, Malaysia, and Korea were classified into the Asian subgroup, and Argentina into the American subgroup.

Statistical analysis {#section9-1470320317741066}
--------------------

The pooled ORs and 95% CIs (confidence intervals) were calculated to assess the risk of EH and TNF-a -308G/A polymorphism. We calculated pooled ORs under A-allele comparison (A vs. G) and dominant model (AA+GA vs. GG). The *Z-*test was used to calculate the combined OR value; *p* ≤ 0.05 was statistically significant.

The *Q* and *I^2^* statistics were used to assess statistical heterogeneity.^[@bibr15-1470320317741066]^ *I^2^* values of 25%, 50%, and 75% represented low, moderate, and high heterogeneity, respectively. Heterogeneity *p * \< 0.10 was considered significant as a significant heterogeneity. The random-effects model (if *p* \< 0.10) or the fixed-effects model (if *p *≥ 0.10) was used to summarize the combined OR. The HWE test (*p* \< 0.05) among the control groups in each study was checked by using an online HWE calculator (<http://ihg.gsf.de/cgi-bin/hw/hwa1.pl>). Funnel plot and Egger's test were used to evaluate the publication bias. A *p*-value \< 0.1 indicated a potential publication bias.^[@bibr16-1470320317741066]^ Sensitivity analysis was performed to assess the stability of the results. Analyses were performed using Stata software, version 10 (StataCorp LP, College Station, Texas, USA) and Review Manager 4.2 (Cochrane Collaboration).

Results {#section10-1470320317741066}
=======

Study selection and subject characteristics {#section11-1470320317741066}
-------------------------------------------

The flow diagram in [Figure 1](#fig1-1470320317741066){ref-type="fig"} summarizes the selection process of this literature review. Based on the inclusion criteria, a total of 10 relevant studies concerning TNF-a -308G/A polymorphism and EH were initially identified. Among the 10 eligible articles, one study was excluded because it was a duplicate.^[@bibr17-1470320317741066]^ Finally, a total of nine case-control studies were identified, including 1437 cases and 1487 controls.^[@bibr18-1470320317741066][@bibr19-1470320317741066][@bibr20-1470320317741066][@bibr21-1470320317741066][@bibr22-1470320317741066][@bibr23-1470320317741066][@bibr24-1470320317741066][@bibr25-1470320317741066]-[@bibr26-1470320317741066]^ These nine studies encompassed one Caucasian and eight Asian studies. The characteristics of the selected studies and the numbers of subjects are shown in [Table 1](#table1-1470320317741066){ref-type="table"}. The included studies were published between 2001 and 2015. The sample sizes range from 166 to 481. Eight studies were conducted in Asian populations and one in an American population. Furthermore, the genotype distributions in the controls of all the included studies were consistent with HWE (*p *\> 0.05).

![Flow diagram of paper screening.](10.1177_1470320317741066-fig1){#fig1-1470320317741066}

###### 

Characteristics of studies included in the meta-analysis.

![](10.1177_1470320317741066-table1)

  --------------------------------------------------------------------------------------------------------------------
  Author\       Year   Country(Ethnicity)    Sample size(Case/Con )   Distribution of genotype   HWE\          
  (Reference)                                                                                    *p*           
  ------------- ------ --------------------- ------------------------ -------------------------- ------- ----- -------
  Sheu WH       2001   China(Asian)          235/246                  190/207                    42/38   3/1   0.593

  Wu XB         2004   China(Asian)          114/114                  90/99                      24/15   0/0   0.452

  Peng CY       2011   China(Asian)          246/208                  209/186                    39/22   8/0   0.421

  Gong YC       2005   China(Asian)          218/195                  192/173                    23/22   3/0   0.404

  Yoo CS        2007   Korea(Asian)          87/79                    78/63                      9/16    0/0   0.317

  Sookoian      2005   Argentina(American)   62/113                   42/96                      18/15   2/2   0.142

  Guo LW        2009   China(Asian)          130/197                  102/174                    28/21   0/2   0.148

  Zhao YY       2014   China(Asian)          182/178                  144/157                    37/19   1/2   0.119

  Ghodsian      2015   Malaysia(Asian)       163/157                  133/142                    28/15   2/0   0.530
  --------------------------------------------------------------------------------------------------------------------

Case = Essential hypertension; Con = Control.

Meta-analysis results and sensitivity analysis {#section12-1470320317741066}
----------------------------------------------

A meta-analysis of all subjects and a subgroup analysis by ethnicity was performed. For the dominant model, heterogeneity was observed (*I^2 ^*= 44.5%, *p* = 0.07) and the original data were combined by using a random-effects model. The summary OR was 1.53 (GG+GA vs. AA: P\<0.00001, 95% CI: 1.25-1.88) by the fixed effects model and 1.54 (*p *= 0.003, 95% CI: 1.16--2.04) by the random-effects model ([Figure 2 TNF-a -308G'](#fig2-1470320317741066){ref-type="fig"}). It was indicated that there was an intensively positive association between allele and EH risk. In the subgroup analysis by ethnicity, significant risk was also found in the Asian population for GG+GA versus AA (*p *= 0.0004, *OR* = 1.47, 95% CI: 1.18--1.81, *p*~heterogeneity ~= 0.10) under the fixed effects model. The allele results (Asian: *p *= 0.0001, OR = 1.48, 95% CI: 1.21--1.80, *p*~heterogeneity ~= 0.17) were consistent with the dominant model.

![Meta-analysis with a random-effects model for the association between EH risk and the TNF-a -308G/A polymorphism (AA+GA vs. GG).\
The OR estimate for each study is marked with a solid black square. The size of the square represents the weight that the corresponding study exerts in the meta-analysis. The CIs of the pooled estimates are displayed as a horizontal line through the diamond; this entire line may be inside the diamond if the CI is narrow.](10.1177_1470320317741066-fig2){#fig2-1470320317741066}

A selected article in the included studies was deleted each time to reflect the influence of the individual data setting on the pooled ORs; no obvious change was observed in any of the pooled ORs following deletion.

Publication bias {#section13-1470320317741066}
----------------

Following confirmation that there was no obvious asymmetry in the funnel plot ([Figure 3](#fig3-1470320317741066){ref-type="fig"}) (AA+AG vs. GG), an Egger test was carried out to verify the symmetry of the funnel plot. The results suggested that there was no publication bias in this study (data not shown).

![Funnel plot for publication bias in selection of studies on the TNF-a -308G/A polymorphism (AA+GA vs. GG).](10.1177_1470320317741066-fig3){#fig3-1470320317741066}

Discussion {#section14-1470320317741066}
==========

In recent years, increasing evidence has shown that inflammation plays an important role in the occurrence and development of EH. Based on the different role in the inflammatory process, inflammatory factors can be divided into pro-inflammatory cytokines and anti-inflammatory cytokines. TNF-a is a cytokine produced by the multinuclear giant cells, with a wide range of biological activities, which not only has the function of regulating the body's immune function, but can also mediate the inflammatory reaction process. TNF-a, as a pro-inflammatory cytokine, can secrete potent contractile vasoactive substance endothelin 1, which can lead to increased blood pressure.^[@bibr27-1470320317741066]^ Increased TNF-a can accelerate lipid peroxidation, which can destroy the structural integrity and function of endothelial cells, causing an imbalance in endothelial cells that secrete active substances. Increased secretion of endothelin by vasodilators and vasoconstriction accelerates vasoconstriction and improves peripheral resistance and blood pressure.

A cross-sectional study of the relationship between TNF-a, interleukin6, C-reactive protein, and other indicators of inflammation and hypertension found that, after adjusting for age, gender, Body mass index, and family history index, TNF-a might be an independent risk factor for EH.^[@bibr28-1470320317741066]^ Another report studied by Kwang-II Kim in 2008 found that the TNF-a level correlated with the fluctuation of blood pressure.^[@bibr29-1470320317741066]^ The TNF-a -308G/A polymorphism could increase TNF-a expression, which is associated with various inflammatory diseases.^[@bibr30-1470320317741066],[@bibr31-1470320317741066]^ Increasing numbers of scholars are exploring scholars the relationship between TNF-a -308G/A polymorphism and EH, but the conclusions are not consistent.18-26 A single study may not draw a comprehensive and reliable conclusion due to the low effectiveness of the tests used. In addition, because of the different frequencies (TNF-a -308G/A) of the different regions and ethnic groups, the extrapolation of the foreign research is limited.

In 2012, Li et al. performed a meta-analysis that only contained seven studies on the relationship between TNF-a -308G/A polymorphism and EH. After that, other researchers published several new case-control studies on this topic in 2014 and 2015.^[@bibr25-1470320317741066],[@bibr26-1470320317741066]^ The same polymorphism was found to play a different role in different ethnic populations. Therefore, for clarification, an updated meta-analysis and subgroup analysis by ethnicity including all the published manuscripts was needed.

Based on our meta-analysis, the results showed that the TNF-a -308G/A polymorphism may be an EH susceptibility gene across populations. In the subgroup analysis, there was an association between the TNF-a -308G/A polymorphism and EH in the Asian population. In our meta-analysis, there was only one study based on a Caucasian population, in Argentina, that found unless the AA+GA gene is responsible for carrying genotype increased the risk of EH. Heterogeneity was the main factor that affected the reliability of the results. Two genetic models had no obvious heterogeneity in our study. Sensitivity analysis and subgroup analysis were used in this study. The ORs and 95% CIs were calculated, and the results were consistent. The overall sensitivity and stability of the study were high.

One of the advantages of this study is that a number of comparable studies have been combined to increase sample size and statistical power, which helps to draw a more convincing result. In our meta-analysis, we established strict literature inclusion and exclusion criteria, and excluded duplicates, incomplete data and non-case-control trials. Furthermore, selection bias was controlled, and to a minimum, which, we believe, supports the objectivity and credibility of the conclusion. Primary hypertension is a multifactorial disease in the genetic background. This study only carried out a single factor analysis of TNF-a gene polymorphism, and had several limitations. First, the literature only included Chinese- and English-language articles, which might have led to a language bias. Second, the time span of each study and the specific detection technology were different, thus, there may have been bias within the study. In addition, although several new studies were included in this meta-analysis, the sample size was still small.

In conclusion, the results of the meta-analysis based on nine studies showed that TNF-a -308G/A polymorphism might increase the risk of EH, at least in the Asian population. Due to the number and level of current clinical trials, the impact of factors such as the level of the author and objective conditions, the above conclusions are yet to be further confirmed by further prospective studies.
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